United States· US:70710-1683_5a3e9c70-b8f8-4866-b128-9f50272c03c0
Famotidine
A famotidine product containing famotidine, registered in United States by Zydus Pharmaceuticals USA Inc.. The same ATC class is registered in 15 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Famotidine is registered in 15 of 19 countries.
Countries holding a registration under ATC A02BA03 (famotidine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Famotidine · ATC A02BA03
15 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of famotidine costs, country by country.
Normalised to the WHO defined daily dose (40 mg), the median price runs from $0.26 in Spain to $0.76 in Italy — a ×3.0 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Famotidine · price per daily dose (40 mg)
USD · FX 28 Sept 2026
- IT Italy$0.76
- FR France$0.59
- ES Spain$0.26
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FAMOTIDINE
- Manufacturer
- Zydus Pharmaceuticals USA Inc.
- Country
- United States (US)
- ATC code
- A02BA03
- ATC class
- Famotidine
- Defined daily dose
- 40 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 10
- ndc1170710168301000 TABLET, FILM COATED in 1 BOTTLE (70710-1683-0)
- ndc117071016831100 TABLET, FILM COATED in 1 BOTTLE (70710-1683-1)
- ndc11707101683330 TABLET, FILM COATED in 1 BOTTLE (70710-1683-3)
- ndc11707101683410 BLISTER PACK in 1 CARTON (70710-1683-4) / 10 TABLET, FILM COATED in 1 BLISTER PACK (70710-1683-2)
- ndc117071016835500 TABLET, FILM COATED in 1 BOTTLE (70710-1683-5)
- ndc1170710-1683-0
- ndc1170710-1683-1
- ndc1170710-1683-3
- ndc1170710-1683-4
- ndc1170710-1683-5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
778 interactions on record for famotidine.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Famotidine · interactions on record
778 records
- 14 severe
- 277 moderate
- 52 minor
- 434 info
Most severe, free to view
- AtazanavirJ05AE08severe
- RilpivirineJ05AG05severe
- DasatinibL01EA02severe
- NeratinibL01EH02severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Famotidine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsFamotidine 20 mg Focus Care, filmomhulde tablettenFocus Care Pharmaceuticals B.V.
- CzechiaFAMOSANPRO.MED.CS Praha a.s.
- IrelandFamotidine 20 mg film-coated tabletsAmdipharm Limited
- FinlandFamotidin HexalHexal A/S
- PolandFamifluxBiofarm Sp. z o.o.
- SpainFAMOTIDINA CINFA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Cinfa S.A.
- FranceFAMOTIDINE EG 20 mg, comprimé pelliculéEG LABO - LABORATOIRES EUROGENERICS
- SwedenFamotidin Vivanta 20 mg Filmdragerad tablettVivanta Generics s.r.o.
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Famosin, Famotidin !$tada
- Bulgaria · Famore 20 Mg, Famore 40 Mg
- Cyprus · Famopsin, Ulcedine
- Czechia · Famosan, Kuladgy
- Germany · Famotidin Ratiopharm, Famotidin Stada
- Estonia · Kuladgy
- Spain · Famotidina Aristo, Famotidina Cinfa
- Finland · Pepcid
- France · Famotidine Eg, Famotidine Eg Labo
- United Kingdom (Northern Ireland) · Famotidine Alissa Healthcare Research, Famotidine Celix Pharma
- Greece · Banatin, Famotidine Beλκα Ελλασ
- Croatia · Confamo, Famosan
- Hungary · Apo-Famotidin, Motidin
- Ireland · Famotidine Amdipharm, Famotidine Clonmel
- Italy · Famotidina Doc, Famotidina Eg
- Lithuania · Kuladgy, Quamatel
- Latvia · Kuladgy, Quamatel
- Malta · Famotidine Clonmel Healthcare
- Netherlands · Famotidine Aurobindo, Famotidine Centrafarm
- Norway · Famotidin Vivanta, Pepcid
- Poland · Famiflux, Famogast
- Portugal · Lasa
- Romania · Famodin, Famotidină Zentiva
- Sweden · Famotidin Vivanta, Pepcid
- Slovakia · Famosan, Famotidin Sl Zentiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fea9c76c-8052-4cf8-b45e-24f04ac31444 GET /v1/drugs/fea9c76c-8052-4cf8-b45e-24f04ac31444?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "20",
"substance": "FAMOTIDINE",
"productndc": "70710-1683",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA216441",
"marketing_category": "ANDA"
}See everything about famotidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.